home / stock / mnkpf / mnkpf quote
Last: | $17.25 |
---|---|
Change Percent: | 1.45% |
Open: | $17 |
Close: | $17.25 |
High: | $17.5 |
Low: | $15.26 |
Volume: | 1,437 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$17.25 | $17 | $17.25 | $17.5 | $15.26 | 1,437 | 10-26-2022 |
$16.5 | $16.5 | $16.5 | $16.5 | $16.5 | 502 | 10-25-2022 |
$16.25 | $16.5 | $16.25 | $16.5 | $16.25 | 2,260 | 10-24-2022 |
$16.5 | $0 | $16.5 | $0 | $0 | 20 | 10-21-2022 |
$16.5 | $16 | $16.5 | $16.5 | $16 | 224 | 10-19-2022 |
$16.5 | $0 | $16.5 | $0 | $0 | 8 | 10-18-2022 |
$16.5 | $15.1 | $16.5 | $16.5 | $15.1 | 2,100 | 10-17-2022 |
$16.5 | $0 | $16.5 | $0 | $0 | 4 | 10-14-2022 |
$16.5 | $16.5 | $16.5 | $16.5 | $16.5 | 100 | 10-13-2022 |
$17 | $0 | $17 | $0 | $0 | 20 | 10-11-2022 |
$17 | $0 | $17 | $0 | $0 | 3 | 10-06-2022 |
$17 | $0 | $17 | $0 | $0 | 3 | 10-05-2022 |
$17 | $0 | $17 | $0 | $0 | 58 | 10-04-2022 |
$17 | $15.75 | $17 | $17.5 | $15.75 | 5,905 | 09-30-2022 |
$16.5 | $17 | $16.5 | $17.9 | $16.5 | 1,013 | 09-29-2022 |
$15 | $15 | $15 | $15 | $15 | 300 | 09-28-2022 |
$15 | $17.88 | $15 | $17.88 | $11.75 | 645 | 09-27-2022 |
$18 | $17.94 | $18 | $18 | $14.01 | 396 | 09-26-2022 |
$17.94 | $0 | $17.94 | $0 | $0 | 11 | 09-23-2022 |
$17.94 | $0 | $17.94 | $0 | $0 | 9 | 09-22-2022 |
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt Company Name:
MNKPF Stock Symbol:
OTCMKTS Market:
Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance PR Newswire Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executi...
Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference PR Newswire DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson , President ...
Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance PR Newswire Launched Terlivaz ® Following U.S. Food and Drug Administration (FDA) Approval in September; Submitted U.S. FDA Premarket Notification Application for Next-Generat...